Come up with a name for your new list and we'll add to it:
Ambit Biosciences raised a round of funding on December 21, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Ambit Biosciences is a biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicat…